Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3886 AL 3900

Advances in developing novel therapeutic strategies for Alzheimer's disease

Cao J, Hou J, Ping J, Cai D.

Mol Neurodegener. 2018 Dec 12;13(1):64. doi: 10.1186/s13024-018-0299-8.

Molecular and Functional Interaction of the Myokine Irisin with Physical Exercise and Alzheimer's Disease

Jin Y, Sumsuzzman DM, Choi J, Kang H, Lee SR, Hong Y.

Molecules. 2018 Dec 7;23(12):3229. doi: 10.3390/molecules23123229.

Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer's Disease Phenotype

Pluta R, Ułamek-Kozioł M, Czuczwar SJ.

Int J Mol Sci. 2018 Dec 12;19(12):4002. doi: 10.3390/ijms19124002.

Alzheimer's disease: understanding homeostasis deregulation to foster development of effective therapies

Nisticò R, Peineau S.

Pharmacol Res. 2019 Jan;139:467-468. doi: 10.1016/j.phrs.2018.12.011. Epub 2018 Dec 13.

The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease

Broom GM, Shaw IC, Rucklidge JJ.

Nutrition. 2019 Apr;60:118-121. doi: 10.1016/j.nut.2018.10.003. Epub 2018 Oct 10.

Efficacy and safety of idalopirdine for Alzheimer's disease: a systematic review and meta-analysis

Matsunaga S, Fujishiro H, Takechi H.

Int Psychogeriatr. 2019 Nov;31(11):1627-1633. doi: 10.1017/S1041610218002156. Epub 2018 Dec 18.

Repetitive Transcranial Magnetic Stimulation Improves Executive Function and Music Rhythm

Padala KP, Hunter CR, Parkes CM, Lensing SY, Padala PR.

J Neuropsychiatry Clin Neurosci. 2019 Spring;31(2):178-180. doi: 10.1176/appi.neuropsych.18100224. Epub 2018 Dec 18.

Biological clocks, some clock-related diseases, and medicinal plants

Deng TS.

Psych J. 2018 Dec;7(4):197-205. doi: 10.1002/pchj.263.

Stem cell therapy in Alzheimer's disease: possible benefits and limiting drawbacks

Alipour M, Nabavi SM, Arab L, Vosough M, Pakdaman H, Ehsani E, Shahpasand K.

Mol Biol Rep. 2019 Feb;46(1):1425-1446. doi: 10.1007/s11033-018-4499-7. Epub 2018 Dec 18.

Atypical PKC: therapeutic target for Alzheimer's?

Farese RV, Sajan MP.

Aging (Albany NY). 2018 Dec 20;11(1):13-14. doi: 10.18632/aging.101730.

Liposome delivery systems for the treatment of Alzheimer's disease

Ross C, Taylor M, Fullwood N, Allsop D.

Int J Nanomedicine. 2018 Dec 12;13:8507-8522. doi: 10.2147/IJN.S183117. eCollection 2018.

Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer's disease: a network meta-analysis of 41 randomized controlled trials

Dou KX, Tan MS, Tan CC, Cao XP, Hou XH, Guo QH, Tan L, Mok V, Yu JT.

Alzheimers Res Ther. 2018 Dec 27;10(1):126. doi: 10.1186/s13195-018-0457-9.

Alzheimer's disease therapeutic candidate SAK3 is an enhancer of T-type calcium channels

Fukunaga K, Izumi H, Yabuki Y, Shinoda Y, Shioda N, Han F.

J Pharmacol Sci. 2019 Feb;139(2):51-58. doi: 10.1016/j.jphs.2018.11.014. Epub 2018 Dec 18.

Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: A randomized, double-blind, controlled trial

Tamtaji OR, Heidari-Soureshjani R, Mirhosseini N, Kouchaki E, Bahmani F, Aghadavod E, Tajabadi-Ebrahimi M, Asemi Z.

Clin Nutr. 2019 Dec;38(6):2569-2575. doi: 10.1016/j.clnu.2018.11.034. Epub 2018 Dec 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias